1. Home
  2. ALGM vs AKRO Comparison

ALGM vs AKRO Comparison

Compare ALGM & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allegro MicroSystems Inc.

ALGM

Allegro MicroSystems Inc.

HOLD

Current Price

$29.36

Market Cap

4.5B

Sector

Technology

ML Signal

HOLD

Logo Akero Therapeutics Inc.

AKRO

Akero Therapeutics Inc.

HOLD

Current Price

$54.48

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALGM
AKRO
Founded
1990
2017
Country
United States
United States
Employees
N/A
67
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.5B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
ALGM
AKRO
Price
$29.36
$54.48
Analyst Decision
Strong Buy
Buy
Analyst Count
10
10
Target Price
$37.40
$73.56
AVG Volume (30 Days)
1.6M
1.6M
Earning Date
10-30-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$788,395,000.00
N/A
Revenue This Year
$22.84
N/A
Revenue Next Year
$14.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.38
$21.34
52 Week High
$38.45
$58.40

Technical Indicators

Market Signals
Indicator
ALGM
AKRO
Relative Strength Index (RSI) 63.30 64.87
Support Level $25.93 $54.22
Resistance Level $29.04 $54.70
Average True Range (ATR) 1.08 0.14
MACD 0.67 -0.12
Stochastic Oscillator 95.89 53.83

Price Performance

Historical Comparison
ALGM
AKRO

About ALGM Allegro MicroSystems Inc.

Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: